Estimating the probability of success in clinical trials is a key factor influencing the decision to fund a development programme for a therapeutic candidate. A higher likelihood of approval increases ...
AI-discovered molecules can have an 80%–90% success rate in Phase 1 clinical studies, a group of researchers from Boston Consulting Group said in a recent peer-reviewed article in the journal Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results